Aluminum fluoride inhibits phospholipase D activation by a GTP-binding protein-independent mechanism  by Li, Liang & Fleming, Norman
Aluminum £uoride inhibits phospholipase D activation by a
GTP-binding protein-independent mechanism
Liang Li, Norman Fleming*
Department of Oral Biology, University of Manitoba, 780 Bannatyne Avenue, Winnipeg, Man. R3E 0W2, Canada
Received 26 July 1999
Abstract Aluminum fluoride (AlF34 ) inhibited guanine nucleo-
tide-activated phospholipase D (PLD) in rat submandibular
gland cell-free lysates in a concentration-dependent response.
This effect was consistent in permeabilized cells with endogenous
phospholipid PLD substrates. Inhibition was not caused by either
fluoride or aluminum alone and was reversed by aluminum
chelation. Inhibition of PLD by aluminum fluoride was not
mediated by cAMP, phosphatases 1, 2A or 2B, or phosphatidate
phosphohydrolase. AlF34 had a similar inhibitory effect on rArf-
stimulated PLD, but did not block the translocation of Arf from
cytosol to membranes, indicating a post-GTP-binding-protein
site of action. Oleate-sensitive PLD, which is not guanine
nucleotide-dependent, was also inhibited by AlF34 , supporting a G
protein-independent mechanism of action. A submandibular
Golgi-enriched membrane preparation had high PLD activity
which was also potently inhibited by AlF34 , leading to speculation
that the known fluoride inhibition of Golgi vesicle transport may
be PLD-mediated. It is proposed that aluminum fluoride inhibits
different forms of PLD by a mechanism that is independent of
GTP-binding proteins and that acts via a membrane-associated
target which may be the enzyme itself.
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1. Introduction
Phospholipase D (PLD) is increasingly recognized as an
important signal-transducing enzyme involved in the regula-
tion of several cellular processes [1,2]. The major substrate for
the enzyme is membrane phosphatidylcholine (PC). The hy-
drolysis product, phosphatidic acid (PA), may itself act as a
signaling molecule, and is also the precursor of additional
regulatory molecules including diacylglycerol, lyso-PA and
arachidonic acid (AA) [1^3]. For example, we previously
showed that in submandibular cells, PA is a prime source of
AA [4], a multipotent regulator of protein synthesis, calcium
£ux and mucin secretion in the model [5]. Two forms of
phosphatidylinositol 4,5-bisphosphate (PIP2)-dependent
PLD, designated PLD1 and PLD2, have been cloned from
mammalian tissues [6,7]. PLD1 is regulated by the small
GTPases, Arf and RhoA and by the enzyme protein kinase
C (PKC). PLD2 has a high constitutive activity and may be
regulated by unknown inhibitory factors [1^3]. An additional
form of fatty acid (oleate)-sensitive PLD has been demon-
strated in brain [8] and other tissues. Most cellular studies
so far reported on the enzyme have dealt with the guanine
nucleotide/Arf-sensitive PLD1.
A number of agonists that activate PLD are known to act
on membrane receptors coupled to heterotrimeric GTP-bind-
ing proteins [9]. In an earlier study we found that muscarinic
stimulation of submandibular cells activated PLD, partially
by acting through the receptor-coupled Gq protein of the
PIP2/phospholipase C (PLC) signal transduction pathway,
with the downstream mediation of PKC [4]. We later demon-
strated that, in the same model, a Gq-independent pathway,
involving the sequential actions of an unidenti¢ed heterotri-
meric G protein and Arf, also led to PLD activation [10]. In
the same study, it was shown that AlF34 too activated PLD in
intact cells, consistent with its e¡ect on other intact cell mod-
els [11,12] and with its known capacity to activate heterotri-
meric G proteins. In this e¡ect, AlF34 mimics the Q-phosphate
group of GTP to stabilize the GK subunit of the regulatory
protein in the transitional state [13,14]. AlF34 reacts only with
heterotrimeric G proteins in this way, and not with small
GTP-binding species such as Arf [15].
Although AlF34 activates PLD in intact cells, it has failed to
activate the enzyme in cell-free extracts of HL60 cells and
neutrophils [16,17]. This prompted us to examine the e¡ects
of this probe on PLD in lysates of submandibular acinar cells
and in permeabilized cells, in an attempt to gain a better
understanding of PLD regulation in this model. We report
here an inhibitory e¡ect of aluminum £uoride on PLD in
submandibular extracts by a mechanism that is independent
of its stimulation of heterotrimeric GTP-binding proteins.
2. Materials and methods
2.1. Materials
Dipalmitoyl-phosphatidylcholine (PC), dioleoyl-phosphatidyletha-
nolamine (PE), and phosphatidylethanol (PEth) were purchased
from Avanti Polar Lipids, Alabaster, AL, USA. PIP2 puri¢ed from
bovine brain was obtained from Sigma-Aldrich, Oakville, Ont., Can-
ada. Dipalmitoyl-[2-palmitoyl-9,10-3H]phosphatidylcholine and dipal-
mitoylphosphatidyl-[methyl-3H]choline were from Dupont NEN
(Mandel Scienti¢c, Guelph, Ont., Canada). [5,6,8,9,11,12,14,15-
3H]AA was a product of Amersham Pharmacia, Baie d’Urfe, Que.,
Canada. GTPQS and Complete Mini Protease inhibitor tablets were
from Boehringer Mannheim, Laval, Que., Canada. Whatman Silica
Gel 60 TLC plates were purchased from Fisher Scienti¢c, Winnipeg,
Man., Canada. Ultrapure sodium £uoride and all the other reagents
were from Sigma-Aldrich.
2.2. Preparation of rat submandibular acinar cells
Submandibular acinar cells from male Sprague-Dawley rats (200^
250 g) were prepared by collagenase dissociation and maintained in
short-term culture in a modi¢ed Hanks’ balanced salt solution as
described previously [4].
2.3. Preparation of submandibular membrane and cytosolic fractions
Fresh isolated rat submandibular acinar cells were resuspended in
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bu¡er A (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM
KH2PO4, 2.5 mM EDTA, 1 mM DTT, pH 7.0). One tablet of Com-
plete Mini protease inhibitor cocktail (Boehringer Mannheim) was
added per 10 ml bu¡er A. The cells were disrupted by homogenization
plus brief sonication. Unbroken cells and nuclei were removed by
centrifugation at 500Ug for 10 min. Total membrane and cytosol
were obtained by centrifugation at 100 000Ug for 90 min. The super-
natant (cytosol) was removed. The pellet (membrane) was resus-
pended in bu¡er A with the same concentration of the protease in-
hibitors. Membrane and cytosol fractions were aliquoted and stored
at 380‡C.
2.4. PLD assays
Cell-free PLD assays were carried out using phospholipid vesicles
(PE/PIP2/PC, in a molar ratio of 16:1.4:1) prepared according to
Brown et al. [16], and containing dipalmitoyl-[2-palmitoyl-9,10-
3H]PC (0.075 WCi per 10 Wl lipid vesicle). PLD activity was assayed
by quantifying radiolabeled PEth, produced in the transphosphatidy-
lation reaction and isolated by thin layer chromatography [4]. To start
the reaction, 10 Wl lipid vesicles and 1% ethanol were added to the
assay system (50 mM HEPES, 80 mM KCl, 3.0 mM MgCl2, 1 mM
DTT, 1 mM EGTA, 1 mM CaCl2, pH 7.0) which contained 50^100
Wg membrane and/or cytosol fraction. In most experiments, 10 WM
GTPQS was used to stimulate PLD activity. The assays were con-
ducted at 37‡C for 20 min in a total assay volume of 60 Wl. The
reaction was stopped, PEth was extracted and quanti¢ed as described
previously [10]. PLD assays in cells permeabilized by 50 Wg/ml digi-
tonin and in intact cells were conducted by labeling the cellular phos-
pholipids with [3H]AA and measuring radiolabeled PEth formation
[10].
Oleate-dependent PLD activity was assayed as described by Mas-
senburgh et al. [8]. 10 Wl phosphatidylcholine vesicles containing 10
nmol of dipalmitoyl-PC and 0.3 WCi of dipalmitoyl-[2-palmitoyl-9,10-
3H]PC were incubated for 30 min in a reaction system that included
Na-HEPES (50 mM, pH 7.2), 4 mM sodium oleate, 1 mM EGTA,
1 mM MgCl2, 50^100 Wg submandibular total cell lysate and 1%
ethanol. Generated PEth, re£ecting PLD activity, was measured as
above.
2.5. Puri¢cation of recombinant myristoylated Arf from Escherichia
coli
Recombinant myristoylated Arf1 protein was puri¢ed from bacteria
according to an established protocol [18]. The E. coli strain which co-
expressed the Arf1 gene and the yeast N-myristoyltransferase gene
(NMT1) was kindly provided by Dr. R. Bhullar, University of Man-
itoba.
2.6. Determination of Arf translocation by Western blotting
Arf translocation was determined in a permeabilized cell system by
an immunoblotting technique as described previously [10]. A polyclo-
nal anti-Arf antibody was kindly provided by Dr. R. Bhullar, Uni-
versity of Manitoba.
2.7. Preparation of Golgi-enriched membrane fractions
Golgi-enriched membrane fractions were prepared from the post-
nuclear supernatant of cell extracts by a modi¢cation of the two-step
sucrose gradient centrifugation procedure of Balch et al. [19]. After
centrifugation at 70 000Ug (av) in a hanging bucket rotor for 4 h,
material at the 0.8/1.2 M sucrose interface (Golgi-enriched mem-
branes) was collected by long-tip pipette. Membranes were stored at
370‡C until use. Protein content was determined by the Bradford
method [20] with the Bio-Rad dye reagent, and 5 Wg membrane pro-
tein used for each PLD assay (see Section 2.4). The enrichment of the
membrane preparations was assessed by assay of the Golgi marker
enzyme, galactosyltransferase [21].
3. Results
3.1. Activation of PLD by AlF34 in intact submandibular cells
Consistent with our previous observation [10], AlF34 , a
widely used activator of heterotrimeric GTP-binding proteins,
stimulated PLD to around four-fold control levels in intact rat
submandibular acinar cells. This e¡ect was dependent on alu-
minum ion concentration, with a maximal response at 3 mM
NaF/2 WM AlCl3 (Fig. 1A). Since £uoride can etch aluminum
ions from lab glassware to form AlF34 [22], all experiments
were carried out in plastic tubes and with ultrapure NaF to
rule out uncontrolled aluminum contamination. NaF alone
did not stimulate PLD. The stimulatory e¡ect of AlF34 on
PLD was blocked by the aluminum ion chelator deferoxamine
(data not shown). From our previous studies on this model, it
is assumed that activation of PLD by aluminum £uoride in
intact cells results from a stimulatory e¡ect on a heterotrimer-
ic GTP-binding protein [4,10].
3.2. Inhibition of GTPQS-stimulated PLD by AlF34 in a
cell-free assay system
In total submandibular lysates (membranes plus cytosol),
Fig. 1. Aluminum £uoride activates PLD in intact cells but inhibits
PLD in cell extracts. A: Aluminum dependence of AlF34 stimulation
of PLD in intact submandibular acinar cells. Cells were radiolabeled
with [3H]AA and then treated with 3 mM NaF plus the indicated
concentrations of AlCl3 in the presence of 1% ethanol as substrate
for the transphosphatidylation reaction. PLD activity was assayed
as described in Section 2. Values are means þ S.D., n = 3. B: Inhibi-
tion of GTPQS-stimulated PLD activity by AlF34 in submandibular
cell extracts. Cell extracts (54 Wg membrane protein plus 30 Wg cyto-
sol protein) were preincubated with or without AlF34 (3 mM NaF,
20 WM AlCl3) for 5 min before the addition of 10 WM GTPQS. In
one group, 100 WM deferoxamine (DEF) was preincubated with cell
extracts for 5 min before the addition of AlF34 . Values are
means þ S.D., n = 3. The average GTPQS response represents the for-
mation of 17.4 pmol PEth in 30 min. *P6 0.01 compared with the
response to GTPQS.
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10 WM GTPQS stimulated PLD activity to about ¢ve-fold
basal level (Fig. 1B). As in other experimental models
[15,16], AlF34 did not activate PLD in this cell-free system.
Unexpectedly, we found that AlF34 potently inhibited GTPQS-
stimulated PLD activity. Inhibition was prevented by the alu-
minum chelator deferoxamine (Fig. 1B). In concentration-ef-
fect studies, either Al3 or F3 was used at a ¢xed dose, while
the other was varied. At 5 WM AlCl3, NaF inhibited GTPQS-
activated PLD in a concentration-dependent response (Fig.
2A). Similarly, with NaF held at 3 mM, inhibition was de-
pendent on Al3 concentration over the range 0^12 WM AlCl3
(Fig. 2B). NaF alone had no e¡ect on PLD activity. AlF34
inhibited PLD not only when it was preincubated with cell
lysates before GTPQS stimulation, but also lowered enzyme
activity in a time-dependent way when it was added to the
assay system after GTPQS stimulation (Fig. 2C). The GTP
analog GTPQS is unhydrolyzable, and not readily displaced
from a G protein. Thus, the capacity of AlF34 to inhibit
PLD after GTPQS stimulation suggests that this e¡ect may
be unrelated to its property of activating heterotrimeric G
proteins.
3.3. Inhibition of GTPQS-dependent PLD by AlF34 in
permeabilized cells
The inhibition of PLD by aluminum £uoride was con¢rmed
in permeabilized cells in a concentration-response e¡ect (Fig.
2D). GTPQS enhanced PLD to approximately 5.5-fold basal
levels. An optimal combination of 20 WM AlCl3/10 mM NaF
inhibited GTPQS-induced PLD activity by 80%. In this assay
system, the PLD substrates are prelabeled endogenous mem-
brane phospholipids, suggesting that the AlF34 inhibition of
PLD observed in the cell-free assay was not an artifact related
to the use of exogenous phospholipid vesicles as substrate.
3.4. Investigation of potential mechanisms of AlF34 inhibition of
PLD
The e¡ects of known aluminum £uoride-sensitive pathways
on PLD activation were investigated. Stimulation of the het-
erotrimeric Gs protein, leading to cAMP elevation, is one of
the classic e¡ects of AlF34 [22], and the elevation of intracel-
lular cAMP has an inhibitory e¡ect on fMetLeuPhe-mediated
PLD activation in neutrophils [23]. We previously reported
cross-talk regulation between cAMP and phospholipid signal-
ing pathways in submandibular cells [24]. However, in the
present study, three activators of the cAMP pathway, cholera
toxin, forskolin, and dbcAMP, failed to show any signi¢cant
e¡ects on either basal or GTPQS-stimulated PLD activity
(data not shown).
Fluoride has been reported to inhibit di¡erent classes of
protein phosphatases [25]. The alteration of phosphorylation
status of regulatory proteins or of PLD itself may potentially
a¡ect PLD activation. Okadaic acid is a known inhibitor of
Fig. 2. Concentration/time dependence of AlF34 inhibition on
GTPQS-stimulated PLD activity in cell extracts or permeabilized
cells. A: Submandibular cell extracts were preincubated with the in-
dicated concentrations of NaF together with a ¢xed concentration
of 5 WM AlCl3 to form the active AlF34 . B: Cell extracts were pre-
incubated with indicated concentrations of AlCl3 together with a
¢xed concentration of 3 mM NaF. In both A and B, 10 WM GTPQS
was used to stimulate PLD activity after AlF34 preincubation for
5 min. Values are means þ S.D., n = 3. C: Time response of AlF34
inhibition on GTPQS-stimulated PLD activity. AlF34 (3 mM NaF+
20 WM AlCl3) was added to the cell-free assay system at di¡erent
time points during the 20 min reaction time course after the reac-
tion had been started by 10 WM GTPQS. Values are means þ S.D.,
n = 3. D: AlF34 e¡ect on GTPQS (100 WM)-stimulated PLD activity
in permeabilized submandibular cells. Cells prelabeled with [3H]AA
were permeabilized by 50 Wg/ml digitonin in the presence of indi-
cated concentrations of NaF and 20 WM AlCl3. Values are means
þ S.D., n = 3.
Fig. 3. AlF34 e¡ect on rArf-stimulated PLD activity and Arf trans-
location. A: [3H]AA-labeled cells were permeabilized with 50 Wg/ml
digitonin, followed by several washes to deplete the cytosolic com-
ponents. Cytosol-depleted cells were preincubated with or without
AlF34 for 5 min, then 10 WM GTPQS plus or minus 1.8 WM re-
combinant myristoylated Arf were added for a 20 min assay period.
Values are means of duplicate assays in a representative experiment,
bars show the variations from the mean. The Arf response repre-
sents the formation of 35 pmol PEth. *P6 0.01 compared with the
response to Arf. B: Lack of e¡ect of aluminum £uoride on the
translocation of Arf from cytosol to membranes. Cells were permea-
bilized by 50 Wg/ml digitonin in the presence or absence of AlF34
(10 mM NaF+20 WM AlCl3) and 10 WM GTPQS for 20 min. Pro-
teins in the membrane and cytosol fractions were separated by
SDS-PAGE and Western blotting was performed with anti-Arf pol-
yclonal antibody as described in Section 2.
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protein phosphatases 1, 2A and 2B [26]. In the concentration
range 0.1 nM^10 WM, okadaic had no e¡ect on either basal or
GTPQS-stimulated PLD activity (data not shown).
Fluoride is also known as an inhibitor of phosphatidate
phosphohydrolase (PAP) [27], an enzyme that converts the
PC hydrolysis product of PLD action, PA, to diacylglycerol
(DAG). We previously demonstrated that the PAP inhibitor
propranolol (100 WM) lowered DAG and elevated PA in sub-
mandibular cells after carbachol stimulation of PLD, raising
the possibility of product inhibitory feedback of the enzyme
by elevated PA [4]. In the present study, however, we found
that inhibition of PAP by propranolol had no e¡ect on PLD
activity, suggesting that the AlF34 inhibitory e¡ect was inde-
pendent of its possible action on PAP (results not shown).
In a previous study, we found that Arf/GTPQS stimulation
of PLD involved the translocation of Arf from cytosol to
membranes [10]. In the present study, rArf stimulation of
PLD in submandibular membranes was also inhibited by
AlF34 (Fig. 3A). However, Western blotting experiments
with an anti-Arf antibody showed that AlF34 treatment did
not prevent GTPQS-induced Arf translocation from cytosol to
membranes (Fig. 3B), suggesting a post-translocation site of
inhibitory action.
3.5. E¡ect of AlF34 on oleate-sensitive PLD
Fatty acid (oleate)-sensitive PLD, which is not guanine nu-
cleotide-dependent, was also detected in submandibular mem-
branes. Stimulation with oleate in membrane preparations
elevated PLD to approximately six-fold control values (Fig.
4). Again, AlF34 inhibited PLD in a concentration-dependent
way (Fig. 4). This e¡ect in a GTP-binding protein-independ-
ent pathway supports the proposal that GTP-binding proteins
are not involved in the aluminum £uoride inhibition of PLD.
3.6. E¡ect of AlF34 on PLD in Golgi-enriched membranes
Golgi-enriched membranes, which are essentially devoid of
endoplasmic reticulum, endosomes and multivesicular vesicles
[29], have been used in several cell types to study PLD acti-
vation and function [28,29]. In the present study, enrichment
of the preparations from submandibular cells was con¢rmed
by assay for galactosyltransferase, a Golgi enzyme marker.
Enzyme activity in extracts of the 0.8/1.2 M sucrose interface
was 19-fold that of total cell membranes (data not shown).
Golgi-enriched membranes from submandibular cells had a
high basal PLD activity, which was approximately 10-fold the
value of that for total cell membranes. Treatment with GTPQS
increased basal levels by a factor of 2.4 (Fig. 5). AlF34 po-
tently inhibited Golgi PLD in both basal and guanine nucleo-
tide-stimulated preparations to almost negligible activities
(Fig. 5).
4. Discussion
Aluminum £uoride is an activator of heterotrimeric G pro-
teins in receptor-coupled signaling pathways. Fluoride alone is
often found to have the same e¡ect, attributed to its capacity
to etch aluminum from laboratory glassware to form the ac-
tive AlF34 species [22]. In intact cells, including neutrophils
[11,12], Cos-7 cells [30] and submandibular acinar cells ([10],
present study), £uoride or AlF34 activates PLD, presumably
via a heterotrimeric GTP-binding protein. Recent evidence
suggests that the G protein, G13, couples to PLD [30]. We
previously showed that in submandibular acinar cells, a het-
erotrimeric G protein and the small GTPase, Arf, may be
sequentially involved in muscarinic receptor-coupled PLD ac-
tivation in the model [10].
Aluminum £uoride is unable to activate PLD in cell ex-
tracts or in assays with puri¢ed components ([16,17], J. Exton,
personal communication). However, AlF34 does activate an-
other phospholipase, PLC, in intact cells, permeabilized cells
and cell extracts [31,32], by its action on the PLC-coupled Gq
regulatory protein. Thus, the inhibitory e¡ect on PLD found
in the present study is not universal for phospholipases and is
not the result of some di¡erence between AlF34 e¡ects in cell-
free versus intact cell conditions. Our ¢ndings also con¢rmed
that AlF34 does not inhibit the enzyme via a Gs-coupled
cAMP elevation in a crosstalk regulatory e¡ect.
Several lines of evidence also suggest that the AlF34 inhib-
itory e¡ect is not dependent on its well-known activation of
heterotrimeric GTP-binding proteins. Guanine nucleotide-sen-
sitive PLD could be inhibited by AlF34 added after GTPQS, a
Fig. 4. AlF34 e¡ect on an oleate-sensitive form of PLD. Cell mem-
branes (60 Wg protein) were preincubated with or without AlF34 for
5 min (10 mM NaF plus 2* or 20** WM AlCl3). 10 nmol dipalmito-
yl-PC and 1% ethanol were added to the bu¡er system which con-
tained 4 mM sodium oleate. PEth was measured as before. Values
are means þ S.D., n = 3. The average activity without inhibitor repre-
sents 16.1 pmol PEth formation. *P6 0.05, **P6 0.01 compared
with oleate-sensitive PLD activity.
Fig. 5. E¡ect of AlF34 on basal and GTPQS-stimulated PLD in a
Golgi membrane-enriched preparation from rat submandibular cells.
Membranes (5 Wg/assay) were incubated with or without AlF34 (10
mM NaF+20 WM AlCl3) for 5 min and then in the presence or ab-
sence of 10 WM GTPQS for 20 min. PLD was assayed as before.
Values are means þ S.D., n = 3.
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non-hydrolyzable GTP analog which binds GTP-binding pro-
teins with a negligible o¡-rate [14], and is not, therefore, easily
replaced by GDP-AlF34 . In addition, oleate-sensitive PLD,
which is not regulated by guanine nucleotide-binding proteins
[8,33], is also inhibited by AlF34 so that there may be a com-
mon regulatory mechanism for di¡erent forms of PLD. Fur-
thermore, AlF34 also inhibited rArf-stimulated PLD activity
but did not a¡ect the translocation of Arf from the cytosol to
membranes. This indicates that the site of action of AlF34 in
PLD inhibition is located at a post-Arf-translocation locus.
Since AlF34 inhibited PLD in the membrane fraction alone, a
non-GTP-binding membrane-associated target is proposed.
This could be a PLD regulatory protein, or the enzyme itself.
PLD has been proposed to regulate intracellular vesicle
transport [34,35], especially that of COP1-coated vesicles
across Golgi stacks [29,39], and abundant PLD activity has
been identi¢ed in Golgi-enriched membranes [28]. Intra-Golgi
transport in a cell-free system is inhibited by AlF34 which
appears to act through an AlF34 -sensitive factor on the Golgi
membrane [36^38]. In the present study, we found that PLD
activity was high in Golgi-enriched membranes from subman-
dibular cells and that this activity was potently inhibited by
AlF34 in both the basal and GTPQS-stimulated condition. It is
therefore possible that AlF34 blocks vesicle transport in the
Golgi by inhibition of PLD. If so, aluminum £uoride should
prove a useful probe in future studies on the role and mech-
anism of action of PLD in intracellular vesicle transport.
In preliminary experiments with rat brain extracts and pu-
ri¢ed plant PLD, AlF34 also inhibited PLD activation (unpub-
lished observation), so that this e¡ect may represent a univer-
sal inhibitory mechanism on di¡erent forms of the enzyme.
This is supported by our ¢ndings on GTPQS/Arf-sensitive and
oleate-sensitive PLD, discussed above. The mode of action of
aluminum £uoride in this e¡ect is unknown. Since plant PLD
requires only a combination of enzyme and simple PC sub-
strate to cause activation [40], the enzyme itself may be the
target for AlF34 action. Kinetic studies on puri¢ed PLD may
clarify this.
Though it is well documented that AlF34 activates PLD in
intact cells, we believe that this is the ¢rst report of its inhib-
ition of the enzyme in cell extracts. This di¡erence most likely
re£ects the fact that in extracts, aluminum £uoride acts on an
inhibition-causing target which is shielded from it in intact
cells, and which may be the enzyme itself. The use of AlF34
in PLD studies has potential value in expanding our knowl-
edge of the enzyme’s regulation and function.
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